or Try an Advanced Search...

    Solid Tumor Cancers Stocks List

    Symbol Grade Name % Change
    NCNA F NuCana plc -3.15
    SLXN F Silexion Therapeutics Ltd. -4.18
    CRDF F Cardiff Oncology, Inc. -2.00
    IMCR D Immunocore Holdings plc 0.50
    INAB D IN8bio, Inc. -0.75
    GNTA C Genenta Science S.p.A. -2.21
    NVCR C NovoCure Limited 3.74
    NEO C NeoGenomics, Inc. 6.50
    MNOV B MediciNova, Inc. 6.50
    CKPT B Checkpoint Therapeutics, Inc. 8.07
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies Shell Companies
    Related Stock Lists: Cancer Medicine Oncology Biotechnology Clinical Medicine Chemotherapy Solid Tumors Biology Brain Tumor Cancer Immunotherapy Glioblastoma Leukemia Lymphoma Pancreatic Cancer Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumor Cancers stocks.

    Symbol Grade Name Weight
    XHE B SPDR S&P Health Care Equipment 1.51
    HTEC C Robo Global Healthcare Technology and Innovation ETF 1.48
    XHS C SPDR S&P Health Care Services ETF 1.45
    CNCR F Loncar Cancer Immunotherapy ETF 1.42
    PSCH B PowerShares S&P SmallCap Health Care Portfolio 1.29
    View all Solid Tumor Cancers ETFs...
    Compare ETFs
    Compare HTEC to XHS Compare XHE to CNCR Compare XHE to HTEC

        Solid Tumor Cancers Stocks Recent News

        Date Stock Title
        Nov 21 NVCR Novocure secures FDA approval for add-ons to brain cancer treatment wearable
        Nov 21 NVCR Novocure gets FDA approval for its HFE transducer arrays for glioblastoma treatment
        Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
        Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
        Nov 20 SLXN Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
        Nov 19 MNOV MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
        Nov 19 IMCR Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode
        Nov 19 NEO NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 18 IMCR Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies Shell Companies
        Related Stock Lists: Cancer Medicine Oncology Biotechnology Clinical Medicine Chemotherapy Solid Tumors Biology Brain Tumor Cancer Immunotherapy Glioblastoma Leukemia Lymphoma Pancreatic Cancer Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors
        Solid Tumor Cancers

        Solid tumor cancers are a type of cancer that forms in solid organs or tissues of the body. These tumors can be benign (non-cancerous) or malignant (cancerous). Solid tumor cancers can occur in any organ or tissue, including the brain, breast, colon, pancreas, and prostate. Treatment for solid tumor cancers typically involves surgery, chemotherapy, radiation, and/or targeted therapy.

        Browse All Tags